British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016

被引：97

作者：

Warren, R. B. ^{[1
]}

Weatherhead, S. C. ^{[2
]}

Smith, C. H. ^{[3
]}

Exton, L. S. ^{[4
]}

Mustapa, M. F. Mohd ^{[4
]}

Kirby, B. ^{[5
]}

Yesudian, P. D. ^{[6
]}

机构：

[1] Univ Manchester, Dermatol Ctr, Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Salford M6 8HD, Lancs, England

[2] Royal Victoria Infirm, Dept Dermatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England

[3] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, London SE1 9RT, England

[4] British Assoc Dermatologists, Willan House,4 Fitzroy Sq, London W1T 5HQ, England

[5] St Vincents Univ Hosp, Elm Pk, Dublin, Ireland

[6] Glan Clwyd Gen Hosp, Sarn Lane, Rhyl LL18 5UJ, Wales

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2016年 / 175卷 / 01期

关键词：

LOW-DOSE METHOTREXATE; PSORIASIS PRACTICAL EXPERIENCE; CUTANEOUS LUPUS-ERYTHEMATOSUS; FOLINIC ACID SUPPLEMENTATION; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; LIVER FIBROSIS; PITYRIASIS LICHENOIDES; COMBINATION THERAPY; ATOPIC-DERMATITIS;

D O I：

10.1111/bjd.14816

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：23 / 44

页数：22

共 207 条

[1] CONCURRENT METHOTREXATE AND ETRETINATE THERAPY FOR PSORIASIS [J].

ADAMS, JD .

ARCHIVES OF DERMATOLOGY, 1983, 119 (10) :793-793

[2]

Agarwal KK, 2008, INDIAN J DERMATOL VE, V74, P481

[3] Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: A randomized, placebo-controlled study [J].

Asawanonda, Pravit ;

Nateetongrungsak, Yaowalak .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (06) :1013-1018

[4] Methotrexate for bullous pemphigoid: Preliminary study [J].

Bara, C ;

Maillard, H ;

Briand, N ;

Celerier, P .

ARCHIVES OF DERMATOLOGY, 2003, 139 (11) :1506-1507

[5] Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1) [J].

Barker, J. ;

Hoffmann, M. ;

Wozel, G. ;

Ortonne, J. -P. ;

Zheng, H. ;

van Hoogstraten, H. ;

Reich, K. .

BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (05) :1109-1117

[6] Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic [J].

Barker, J. ;

Horn, E. J. ;

Lebwohl, M. ;

Warren, R. B. ;

Nast, A. ;

Rosenberg, W. ;

Smith, C. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (07) :758-764

[7]

Baughman RP, 2000, SARCOIDOSIS VASC DIF, V17, P60

[8] Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris [J].

Baum, Sharon ;

Greenberger, Shoshana ;

Samuelov, Liat ;

Solomon, Michal ;

Lyakhovitsky, Anna ;

Trau, Henri ;

Barzilai, Aviv .

EUROPEAN JOURNAL OF DERMATOLOGY, 2012, 22 (01) :83-87

[9] TOXIC HEPATITIS DUE TO COMBINATION THERAPY WITH METHOTREXATE AND ETRETINATE IN PSORIASIS [J].

BECK, HI ;

FOGED, EK .

DERMATOLOGICA, 1983, 167 (02) :94-96

[10] Paternal Exposure to Methotrexate and Pregnancy Outcomes [J].

Beghin, Delphine ;

Cournot, Marie-Pierre ;

Vauzelle, Catherine ;

Elefant, Elisabeth .

JOURNAL OF RHEUMATOLOGY, 2011, 38 (04) :628-632

← 1 2 3 4 5 6 7 8 9 10 →